The Medicines Patent Pool is improving access to essential medication where it’s most needed, but does it make economic sense?

A new UN-backed initiative is enabling qualified generic manufacturers to develop, produce and supply vital medicines such as antivirals independently. By reducing the cost of essential medicines, pooled licensing particularly benefits low- and middle-income countries, in sub-Saharan Africa, for instance. Maxim Studio/Shutterstock (no reuse), CC BY The Medicines Patent Pool (MPP) is a not-for-profit organisation founded in 2010 with the support of the United Nations. Its mission is to improve…